CoChat

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach

Open access
Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony W. H., Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel, Pinato, David J., Sharma, Rohini, Ottaviani, Diego, Jang, Jeong W., Labeur, Tim A., van Delden, Otto M., Pirisi, Mario, Stern, Nick, Sangro, Bruno, Meyer, Tim, Fateen, Waleed, García‐Fiñana, Marta, Gomaa, Asmaa, Waked, Imam, Rewisha, Eman, Aithal, Guru P., Travis, Simon, Kudo, Masatoshi, Cucchetti, Alessandro, Peck‐Radosavljevic, Markus, Takkenberg, R.B., Chan, Stephen L., Vogel, Arndt, Johnson, Philip J. · 2020 · Hepatology
Cited by 133

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and Aims: The heterogeneity of intermediate‐stage hepatocellular carcinoma (HCC) and the widespread use of transarterial chemoembolization (TACE) outside recommended guidelines have encouraged the development of scoring systems that predict patient survival. The aim of this study was to build and validate statistical models that offer individualized patient survival prediction using response to TACE as a variable. Approach and Results: Clinically relevant baseline parameters were collected for 4,621 patients with HCC treated with TACE at 19 centers in 11 countries. In some of the centers, radiological responses (as assessed by modified Response Evaluation Criteria in Solid Tumors [mRECIST]) were also accrued. The data set was divided into a training set, an internal validation set, and two external validation sets. A pre‐TACE model (“Pre‐TACE‐Predict”) and a post‐TACE model (“Post‐TACE‐Predict”) that included response were built. The performance of the models in predicting overall survival (OS) was compared with existing ones. The median OS was 19.9 months. The factors influencing survival were tumor number and size, alpha‐fetoprotein, albumin, bilirubin, vascular invasion, cause, and response as assessed by mRECIST. The proposed models showed superior predictive accuracy compared with existing models (the hepatoma arterial embolization prognostic score and its various modifications) and allowed for patient stratification into four distinct risk categories whose median OS ranged from 7 months to more than 4 years. Conclusions: A TACE‐specific and extensively validated model based on routinely available clinical features and response after first TACE permitted patient‐level prognostication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31022

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Han, G., Berhane, S., Toyoda, H., Bettinger, D., Elshaarawy, O., Chan, A. W. H., Kirstein, M., Mosconi, C., Hucke, F., Palmer, D., Pinato, D. J., Sharma, R., Ottaviani, D., Jang, J. W., Labeur, T. A., van Delden, O. M., Pirisi, M., Stern, N., Sangro, B., Meyer, T., Fateen, W., García‐Fiñana, M., Gomaa, A., Waked, I., Rewisha, E., Aithal, G. P., Travis, S., Kudo, M., Cucchetti, A., Peck‐Radosavljevic, M., Takkenberg, R. B., Chan, S. L., Vogel, A., & Johnson, P. J.
Venue
Hepatology
Published
2020-05-27
Volume
72
Issue
1
Pages
198-212
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2984620290
Cited by
133
References
3
FWCI
9.35
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.